Cargando…
Identifying Biomarkers of Wharton’s Jelly Mesenchymal Stromal Cells Using a Dynamic Metabolic Model: The Cell Passage Effect
Because of their unique ability to modulate the immune system, mesenchymal stromal cells (MSCs) are widely studied to develop cell therapies for detrimental immune and inflammatory disorders. However, controlling the final cell phenotype and determining immunosuppressive function following cell ampl...
Autores principales: | Laflaquière, Benoît, Leclercq, Gabrielle, Choey, Chandarong, Chen, Jingkui, Peres, Sabine, Ito, Caryn, Jolicoeur, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876007/ https://www.ncbi.nlm.nih.gov/pubmed/29495309 http://dx.doi.org/10.3390/metabo8010018 |
Ejemplares similares
-
Effects of maternal obesity on Wharton’s Jelly mesenchymal stromal cells
por: Badraiq, Heba, et al.
Publicado: (2017) -
The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells
por: Vieira Paladino, Fernanda, et al.
Publicado: (2019) -
Wharton’ jelly mesenchymal stromal cell therapy for ischemic brain injury
por: Wu, Kuo-Jen, et al.
Publicado: (2018) -
Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells
por: Davies, John E., et al.
Publicado: (2017) -
AFM-based Analysis of Wharton’s Jelly Mesenchymal Stem Cells
por: Szydlak, Renata, et al.
Publicado: (2019)